Literature DB >> 11953089

[Report on fourth national epidemiological sampling survey of tuberculosis].

Hongjin Duanmu.   

Abstract

OBJECTIVE: To investigate the epidemiological trend of tuberculosis, to evaluate the efficacy of control measures and to provide scientific basis for making National Tuberculosis Control Programme 2001 approximately 2010.
METHODS: Tuberculin testing was carried out among 0 approximately 14 years old children; fluroscopy was carried out for >/= 15 years old population and children with >/= 10 mm reaction of tuberculin testing; chest X-ray film, sputum smear and culture were done for the patients of fluroscopy abnormal and suspects of tuberculosis symptom (persistent cough for 3 weeks or more); drug sensitivity test was done for the patients with culture positive; a retrospective study of tuberculosis mortality in 1999 was conducted at all investigation points; social economic study was done for the active pulmonary tuberculosis cases; the survey of tuberculosis infection rate for all population was carried out in 59 investigation points.
RESULTS: The population actually examined in this survey numbered 365 097. The examination rate was more than 95%. The prevalence of active pulmonary tuberculosis was 367/100 000, the prevalence of smear positive pulmonary tuberculosis was 122/100 000 and the prevalence of bacteriological positive pulmonary tuberculosis was 160/100 000. In comparison with 1979, the annual reduction rates were 4.5% for the standardized prevalence of active pulmonary tuberculosis and 3.8% for the standardized prevalence of smear positive pulmonary tuberculosis. In comparison with 1990, the annual reduction rates were 5.4% and 3.2%, respectively. The smear positive prevalence standardized showed a 44.4% decrease in the regions of implementing project of Health V but only 12.3% decrease in the regions without the project. The prevalence in the west region was higher than national average prevalence.
CONCLUSIONS: The epidemic of tuberculosis is still serious and prevalence decrease was slow. The governments at different levels must pay more attention to tuberculosis control programme, increase budget, implement DOTS strategy.

Entities:  

Mesh:

Year:  2002        PMID: 11953089

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  42 in total

1.  Association between SNPs in microRNA-machinery genes and tuberculosis susceptibility in Chinese Tibetan population.

Authors:  Xingbo Song; Siyue Li; MeiLang QuCuo; MeiLang Zhou; Yi Zhou; Xin Hu; Juan Zhou; Xiaojun Lu; Jun Wang; Wei Hua; Yuanxin Ye; Binwu Ying; Lanlan Wang
Journal:  Mol Biol Rep       Date:  2013-10       Impact factor: 2.316

2.  The novel human MRC1 gene polymorphisms are associated with susceptibility to pulmonary tuberculosis in Chinese Uygur and Kazak populations.

Authors:  Xing Zhang; Xiang Li; Wanjiang Zhang; Liliang Wei; Tingting Jiang; Zhongliang Chen; Chunping Meng; Jiyan Liu; Fang Wu; Chong Wang; Fujian Li; Xiaojun Sun; Zhongjie Li; Ji-Cheng Li
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

3.  Acute respiratory distress syndrome in one patient with gout complicated by severe pulmonary tuberculosis: report of one case and literature review.

Authors:  Wei Wang; Yu Zhou; Zhenjiao Su; Li Luo; Ling Zhao
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

4.  Clinical evaluation of a homemade enzyme-linked immunospot assay for the diagnosis of active tuberculosis in China.

Authors:  Xueqiong Wu; Qiaoke Li; Yan Liang; Yourong Yang; Junxian Zhang; Jianqin Liang; Lan Li; Fakuan Tang; Ansheng Wang
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

5.  Spoligotypes of Mycobacterium tuberculosis from different Provinces of China.

Authors:  Haiyan Dong; Zhiguang Liu; Bing Lv; Yuanyuan Zhang; Jie Liu; Xiuqin Zhao; Jinghua Liu; Kanglin Wan
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

6.  A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy.

Authors:  Xi Xie; Jin-Wei Chen; Fen Li; Jing Tian; Jie-Sheng Gao; David Zhang
Journal:  Clin Exp Med       Date:  2010-12-16       Impact factor: 3.984

7.  The role of ABC efflux pump, Rv1456c-Rv1457c-Rv1458c, from Mycobacterium tuberculosis clinical isolates in China.

Authors:  Pei Hao; Zhang Shi-Liang; Liu Ju; Dai Ya-Xin; Huang Biao; Wang Xu; Hu Min-Tao; Kuai Shou-Gang; Wang Ke
Journal:  Folia Microbiol (Praha)       Date:  2011-11-15       Impact factor: 2.099

8.  Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China.

Authors:  Xiaoliang Yuan; Tiantuo Zhang; Kazuyoshi Kawakami; Jiaxin Zhu; Hongtao Li; Jianping Lei; Shaohua Tu
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

9.  Evaluation of the characteristics of the enzyme-linked immunospot assay for diagnosis of active tuberculosis in China.

Authors:  Linchuan Wang; Yan Yu; Wei Chen; Jin Feng; Jinyuan Wang; Heping Zhao; Lietin Ma; Bo Yang; Yanfen Ma; Pei Dang
Journal:  Clin Vaccine Immunol       Date:  2015-03-04

Review 10.  Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis.

Authors:  Mohammed Hammoudeh; Abdurhman Alarfaj; Der-Yuan Chen; Hachemi Djoudi; Ehab Youseif; Jian Zhu
Journal:  Clin Rheumatol       Date:  2012-12-15       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.